MODIFICATIONS IN RISK CLASSIFICATION OF ACUTE MYELOID LEUKEMIAS UNDERGOING LESS INTENSIVE CHEMOTHERAPY COMPARING THE 2022 AND 2024 STRATIFICATIONS OF THE EUROPEAN LEUKEMIANET AND THEIR IMPACT ON TREATMENT DECISION, RESPONSE RATES AND OUTCOMES OF A BRAZILI LM Brandão; JA Balthazar; NM Santana; B Aires; ML Garcia; GA Peruzini; BB Cal; JF Campos; AG Braga; JC Amarante; V Bovolenta; MM Nascimento; JS Filho;

INTESTINAL PRIMARY MYELOID SARCOMA AS AN ISOLATED PRESENTATION WITHOUT BONE MARROW INVOLVEMENT: CASE REPORT AND NARRATIVE REVIEW. LM Brandão; JA Balthazar; NM Santana; MDL Garcia; GA Peruzini; B Aires; BB Cal; AGO Braga; JC Amarante; MDM Nascimento; JS Filho;

EXPERIÊNCIA INICIAL COM O PROTOCOLO HD21 (BRECADD) NO TRATAMENTO DO LINFOMA DE HODGKIN: DADOS DE VIDA REAL DE TRÊS CENTROS DE REFERÊNCIA BRASILEIROS GA Peruzini; JA Balthazar; MdL Garcia; BA Souza; BB Cal; NM Santana; LM Brandão; R Dalfeor; TTM Moura; AGO Braga; H Villefort; VdA Bovolenta; T Fischer; J Schimdt; TMB Silveira;